Eli Lilly, IU partner to expand Alzheimer’s clinical trials, Big Ten Championship returns to Indy

Eli Lilly and Co. and Indiana University announce a new partnership to expand clinical trial access across Indiana and advance Alzheimer’s disease care and research, including an investment of up to $40 million over five years. The work will be based at the IU Launch Accelerator for Biosciences, or IU LAB, a $172 million facility under construction at 16 Tech in Indianapolis that is set to open in 2027. Business of Health reporter Kylie Veleta explains what the clinical trial focus means for patients, plus new diagnostic tools such as a blood test developed by Roche and Lilly, and the plan to train more specialists, including nurse practitioners and physician assistants. Gerry Dick goes one-on-one with Eli Lilly CEO Dave Ricks on innovation in Indiana, including the company’s 150th anniversary next year and its LEAP Innovation District investment in Lebanon. Also in this episode: the Big Ten championship matchup between IU and Ohio State and the projected economic impact of more than $25 million for downtown Indianapolis, plus Evansville-based Escalade Sports and its Onix brand on pickleball’s growth, including participation up about 300% in recent years and equipment sales projected to reach nearly $2 billion by 2032.